Type 2 Diabetes

A recent study published in the journal of the European Journal of Endocrinology found significant benefits of vitamin D supplementation on the development and progression of diabetes.

A systematic review and meta-analysis of observational studies assessing the association between plant-based dietary patterns and the risk of type 2 diabetes among adults, provides the strongest evidence to date that eating a plant-based diet does indeed lower the risk of type 2 diabetes.

Several new generics available to treat neuropathic pain linked to diabetic peripheral neuropathy, fibromyalgia partial onset seizures, and other conditions.

A recent study of more than 12 million people from 10 countries found that the risk of heart failure associated with diabetes was greater in women than in men. 



George Bakris, MD, outlines the difficulties clinicians face when treating diabetic kidney disease in an aging population.

Released the day following President Trump's address, results of a study from investigators at UCSF highlight issues in care of patients with chronic kidney disease.

Patients who are at high-risk of developing type 1 diabetes may be able to delay the progression of the condition with teplizumab treatment, a new study shows.

A recent study has found that microvascular disease anywhere in the body is independently associated with a higher risk of lower limb amputation.

A recent study of 50 inactive adults found that different modalities of exercise can have varying effects on pericardial and epicardial adipose tissue mass.

A recent study of more than 50,000 found that antidepressant use could reduce a third of deaths among diabetic patients with depression.

Recent study finds that positron emission tomography myocardial perfusion imaging can help identify diabetic patients at increased risk of heart attack.

Eli Lilly Co. and Boehringer Ingelheim Pharmaceuticals Inc. announced that empagliflozin (Jardiance) has received a Fast Track designation from the FDA.

Late-in-life weight gain or weight loss appears to be associated with an increased risk of dementia, shows a Korean study of 67,219 men and women between 60-79 years old.

A new retrospective cohort finds that patients with untreated obstructive sleep apnea face a two-fold greater risk of developing T2D.

A recent study found that plant-based diets can lead to changes in gut microbiota that correlate with weightloss and fat reduction.

A single course of treatment with teplizumab delayed the development of type 1 diabetes in at-risk teens and children, shows a study presented at the American Diabetes Association annual meeting earlier this month.

Diabetes complications in young adults with type 2 diabetes are occurring in unusually high rates, researchers reported at the American Diabetes Association annual meeting held earlier this month in San Francisco.

Christopher Sorli, MD, vice president of medical affairs at Sanofi, discusses the results of a recent trial examining insulin glargine plus lixisenatide.

After Janssen's submission of an sNDA in March, results of the CREDENCE subgroup analyses were among the most anticipated presentations at ADA 2019.

A study presented at ADA 2019 examined the efficacy of sitagliptin compared with dapagliflozin in t2d patients 65 years old and older.

FDA has announced the approval of liraglutide injections for treatment of type 2 diabetes among pediatric patients.

A 6-month study examining the effects of hepatic-directed prandial insulin in patients with type 1 diabetes mellitus was presented at ADA 2019.

Osama Hamdy, MD, PhD, discusses the impact of a 10-year study observing the impact of lifestyle interventions among diabetes patients in real-world clinical practice.

Investigators presented results of a study that analyzed renal function and markers of kidney damage in more than 1,000 patients in two randomized trials examining ertugliflozin.

A study analyzing the renal outcomes of the DECLARE-TIMI 58 trial were presented at ADA 2019 in San Francisco, CA.